Severe sepsis caused by serious gastrointestinal infection in sJIA patients treated with IL-6 receptor antagonist: a case report

• Váldodahkkit: Meng Xu (Dahkki), Congcong Liu (Dahkki), Lishuang Guo (Dahkki), Sirui Yang (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: BMC, 2020-03-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Background Interleukin (IL)-6 plays an essential role in the pathogenesis of systemic juvenile idiopathic arthritis (sJIA). Tocilizumab (TCZ), a kind of biological agent against both membrane and soluble IL-6 receptor, is the only biological agent approved for the treatment of sJIA in China...